- Home
- ISPR vs LFMD Comparison
ISPR vs LFMD Comparison
Compare ISPR & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPR | LFMD |
|---|---|---|
| Founded | 2010 | 1994 |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.8M | 190.9M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ISPR | LFMD |
|---|---|---|
| Price | $1.73 | $3.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $7.50 | ★ $9.14 |
| AVG Volume (30 Days) | 156.0K | ★ 1.3M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $127,494,304.00 | N/A |
| Revenue This Year | N/A | $16.11 |
| Revenue Next Year | $14.31 | $20.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.44 | $2.60 |
| 52 Week High | $4.68 | $15.34 |
Technical Indicators
Market Signals| Indicator | ISPR | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 44.07 |
| Support Level | $1.53 | $3.43 |
| Resistance Level | $2.70 | $4.19 |
| Average True Range (ATR) | 0.22 | 0.25 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 6.12 | 9.93 |
Price Performance
Historical ComparisonAbout ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.
About LFMD LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.